About
Julian A. Hiscox is Chair in Infection and Global Health. He is an Executive Dean for the Institute of Infection, Veterinary and Ecological Sciences and Deputy Associate Pro-Vice Chancellor for Research and Impact in the Faculty of Health and Life Sciences. He has a BSc in Genetics from University College London (1991) and a PhD in Virology from the University of Reading (1994). Julian completed post-doctoral training at the University of Alabama at Birmingham (USA) and the Institute for Animal Health (Compton, UK). In 1999 he was appointed as a Lecturer in Virology at the University of Reading and then moved to the University of Leeds in 2003 where he was subsequently a Senior Lecturer and Reader in Virology. In 2012 he was recruited to the University of Liverpool as a Chair. His research group, composed of nine PDRAs and four PhD students, focuses on viral respiratory infections such as SARS-CoV-2, MERS-CoV and seasonal human coronaviruses and and emerging threats including Ebola virus and Mpox. The group is also interested in biological and chemical threat agents and applying AI and machine learning approaches to inform functional approaches. During the COVID-19 pandemic, for the UK Government, Julian was a co-opted member of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). This group advises the government on the threat posed by new and emerging respiratory viruses and he was an occasional participant at the Scientific Advisory Group for Emergencies (SAGE). He was also a member of the Scientific Advisory Group for Antibody Testing. He is currently a member of NERVTAG until 2026. Julian is Director of the BBSRC/DEFRA funded UK-International coronavirus network. He holds an adjust position at the A*STAR Infectious Diseases Labs (IDL) in Singapore.
Funded Fellowships
- Leverhulme Research Fellowship (Leverhulme Trust, 2009)